![Sheldon Sloan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheldon Sloan
Technik-/Wissenschafts-/F&E-Leiter bei
SPYRE THERAPEUTICS, INC.
Profil
Sheldon Sloan is Chief Medical Officer at Spyre Therapeutics, Inc. since 2024.
Formerly, Chief Medical Officer at Abivax SA from 2023 to 2024.
Education includes graduate degree from the University of Pennsylvania, undergraduate degree from Illinois Urbana Champaign University of, and doctorate from Rush Medical College.
Aktive Positionen von Sheldon Sloan
| Unternehmen | Position | Beginn |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2024 |
Ehemalige bekannte Positionen von Sheldon Sloan
| Unternehmen | Position | Ende |
|---|---|---|
| ABIVAX | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2024 |
Ausbildung von Sheldon Sloan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
